Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Dr. Stefan Warmuth, PhD
SVP, Head Technology and CMC at Numab Therapeutics AG
Speaker

Profile

Stefan is heading discovery and CMC activities at Numab as well as technology projects. This includes antibody discovery, protein engineering, analytics, and formulation, USP and DSP development. He is responsible for the CMC strategy and oversees the manufacturing activities of the international network of external CMOs. Stefan studied biochemistry in Tübingen and Zurich and graduated with a degree in Biochemistry from the ETH Zurich and obtained his PhD in Structural Biology and Biochemistry from the University of Zurich.

Agenda Sessions

  • Multispecific Antibodies: Design, Function, and Developability

    9:15am